R&D

Done Differently

Accelerating the Global Development of Innovative Biopharmaceutical Products

Latest news

Drug Development is a Journey

Let’s get there together.

We are a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers. We seek to utilize our team’s deep drug development experience to maximize the potential of our lead development candidate, firmonertinib (previously known as furmonertinib), and advance a pipeline of novel oncology therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization. We forge strategic collaborations and work closely with our partners as we develop these medicines that otherwise may not reach global populations.

Discover

Our team’s deep knowledge in oncology allows us to identify novel therapeutic programs with strong biologic and scientific rationale that we believe have the potential to offer differentiated safety and efficacy profiles to cancer patients.

Partner & Collaborate

We establish partnerships to in-license promising drug candidates and leverage our business development acumen to build a highly competitive pipeline that we are uniquely positioned to bring to global patient communities.

Develop

Based on our extensive experience working with regulatory agencies, we design development strategies that maximize the potential of the drug candidate and have a clear regulatory path to approval.